GenSight Biologics

(OTC) GSGTF

Current Price$0.09

Market Cap$21.10M

Since IPO (2018)-99%

5 Year-99%

1 Year-63%

1 Month-53%

GenSight Biologics Financials at a Glance

Market Cap

$21.10M

Revenue (TTM)

€1.50M

Net Income (TTM)

-€26.04M

EPS (TTM)

-$0.09

P/E Ratio

-0.99

Dividend

$0.00

Beta (Volatility)

-124.20 (Low)

Dividend

$0.00

Beta (Volatility)

-124.20 (Low)

Price

$0.09

Volume

400

Open

$0.09

Price

$0.09

Volume

400

Open

$0.09

Previous Close

$0.09

Daily Range

$0.09 - $0.09

52-Week Range

$0.09 - $0.24

Estimated Earnings Date

Jul 23, 2026

Dividend

$0.00

Beta (Volatility)

-124.20 (Low)

Price

$0.09

Volume

400

Open

$0.09

Previous Close

$0.09

Daily Range

$0.09 - $0.09

52-Week Range

$0.09 - $0.24

Estimated Earnings Date

Jul 23, 2026

GSGTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GenSight Biologics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Laurence Rodriguez

Website

www.gensight-biologics.com

Headquarters

Paris, 75012, FR

GSGTF Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-1168400.00%

Net Income Margin

-1203600.00%

Return on Equity

42.20%

Return on Capital

N/A

Return on Assets

-145.78%

Earnings Yield

-1.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$21.10M

Shares Outstanding

234.47M

Volume

400

Avg. Volume

6.468

Financials (TTM)

Gross Profit

€1.50M

Operating Income

-€29.02M

EBITDA

-€21.76M

Operating Cash Flow

-€22.58M

Capital Expenditure

€6.49M

Free Cash Flow

-€23.97M

Cash & ST Invst.

€2.41M

Total Debt

€12.86M

GenSight Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

-€47.00K

+83.4%

Gross Profit

-€47.00K

+98.0%

Gross Margin

100.00%

N/A

Market Cap

$21.10M

N/A

Market Cap/Employee

$1.32M

N/A

Employees

N/A

Net Income

-€5.07M

+64.5%

EBITDA

-€4.53M

+60.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

€2.41M

+13.1%

Total Debt

€12.86M

-30.2%

Accounts Receivable

€1.58M

+157540.9%

Inventory

€0.00

N/A

Long Term Debt

€9.22M

+49.8%

Short Term Debt

€3.64M

-79.0%

Return on Assets

-1.46%

N/A

Return on Invested Capital

2.65%

N/A

Free Cash Flow

-€7.88M

+7.0%

Operating Cash Flow

-€6.49M

+23.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BOVNFBioInvent International AB (publ)

BOVNFBioInvent International AB (publ)$3.29+0.00%

VBIZFViva Biotech Holdings

VBIZFViva Biotech Holdings$0.16+0.00%

SOLTFNxera Pharma Co., Ltd.

SOLTFNxera Pharma Co., Ltd.$6.00-5.81%

BPMUFBasilea Pharmaceutica AG

BPMUFBasilea Pharmaceutica AG$60.28+0.00%

AGYTFAllergy Therapeutics plc

AGYTFAllergy Therapeutics plc$0.15+7.14%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

NOKNokia

NOKNokia$12.07-0.07%

RIVNRivian Automotive

RIVNRivian Automotive$18.63+0.08%

Questions About GSGTF

What is the current price of GenSight Biologics?

GenSight Biologics is trading at $0.09 per share.

What is the 52-week range for GenSight Biologics?

Over the past 52 weeks, GenSight Biologics has traded between $0.09 and $0.24.

How much debt does GenSight Biologics have?

As of the most recent reporting period, GenSight Biologics reported total debt of €15.11M.

How much cash does GenSight Biologics have on hand?

GenSight Biologics reported €2.84M in cash and cash equivalents in its most recent financial results.

What is GenSight Biologics’s dividend yield?

GenSight Biologics does not currently have a dividend yield.

GenSight Biologics

GenSight Biologics Financials at a Glance

GSGTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About GenSight Biologics

GSGTF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

GenSight Biologics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GSGTF

What is the current price of GenSight Biologics?

What is the 52-week range for GenSight Biologics?

How much debt does GenSight Biologics have?

How much cash does GenSight Biologics have on hand?

What is GenSight Biologics’s dividend yield?

Premium Investing Services